Zobrazeno 1 - 10
of 20
pro vyhledávání: '"ZENTA SETO"'
Autor:
Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inomata
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background Pulmonary sarcomatoid carcinoma is a rare tumor that is resistant to cytotoxic agents. This observational study aimed to evaluate the detection rate of driver gene alteration and the efficacy of targeted therapy for pulmonary sarc
Externí odkaz:
https://doaj.org/article/0daef32daf774bb8b141fae7e8643c1d
Autor:
Minehiko Inomata, Masahiro Matsumoto, Naoki Takata, Kana Hayashi, Zenta Seto, Takahiro Hirai, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Immune checkpoint inhibitors have significantly improved the prognosis in patients with non-small cell lung cancer, compared with cytotoxic agents. However, the prediction of treatment response is often difficult, even after assessing the tu
Externí odkaz:
https://doaj.org/article/b0def5af260d4ffb910a8901979993fb
Autor:
Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizushima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1618-1623 (2023)
Abstract Objective Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs) for pulmonary sarcomatoid carcinoma. This multicenter observational study was conducted to evaluate the efficacy of systemic ICI therapy and chemo
Externí odkaz:
https://doaj.org/article/d017de19d4e6443389f1d93a76555a9a
Autor:
Minehiko Inomata, Masahiro Matsumoto, Isami Mizushima, Kana Hayashi, Zenta Seto, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
The Egyptian Journal of Bronchology, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Purpose We conducted a retrospective analysis of the data of patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to investigate the associations between clinical factors and the overall survival. M
Externí odkaz:
https://doaj.org/article/8f2fac69bfef4d0bbfcfa51ee111cb99
Autor:
TAKAHIRO HIRAI, MINEHIKO INOMATA, SHUHEI MINATOYAMA, MOE HASHIZUME, NAOKI TAKATA, KANA HAYASHI, ZENTA SETO, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHINICHI TANAKA, AKIRA NOGUCHI, TSUTOMU SATO
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1509-1511, 3p
Autor:
MINEHIKO INOMATA, MASAHIRO MATSUMOTO, ISAMI MIZUSHIMA, ZENTA SETO, KANA HAYASHI, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI, KAZUYUKI TOBE
Publikováno v:
Cancer Diagn Progn
Background/Aim: The association between tumor PD-L1 expression and the rate of acquisition of the T790M mutation during treatment with first-/second-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is a matter of stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef7fc1cb0c5dbce50a80c54e706eb8f8
https://europepmc.org/articles/PMC9066543/
https://europepmc.org/articles/PMC9066543/
Autor:
Ryuji Hayashi, Naoki Takata, Shingo Imanishi, Shoko Matsui, Takahiro Hirai, Kotaro Tokui, Seisuke Okazawa, Kenta Kambara, Kazuyuki Tobe, Nozomu Murayama, Zenta Seto, Toshiro Miwa, Minehiko Inomata, Kana Hayashi
Publikováno v:
Internal Medicine
Objective The aim of the present study was to analyze the relationship between the patient characteristics and the timing of provision of an explanation about "Do Not Attempt Resuscitation (DNAR)" by attending physicians to advanced lung cancer patie
Autor:
Zenta Seto, Kotaro Tokui, Shoko Matsui, Toshiro Miwa, Kenta Kambara, Shingo Imanishi, Naoki Takata, Minehiko Inomata, Ryuji Hayashi, Nozomu Murayama, Seisuke Okazawa
Publikováno v:
Tumori. 107(6)
Background: Small cell lung cancer (SCLC) is a very aggressive cancer and recurrence is inevitable. Treatment of recurrent disease is important for improving the prognosis of patients with SCLC. Methods: We conducted a retrospective observational stu
Autor:
Kenta Kambara, Minehiko Inomata, Seisuke Okazawa, Shingo Imanishi, Kotaro Tokui, Isami Mizushima, Chihiro Taka, Kana Hayashi, Toshiro Miwa, Masahiro Matsumoto, Kazuyuki Tobe, Ryuji Hayashi, Shoko Matsui, Zenta Seto
Purpose We conducted a retrospective analysis of the data of patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to investigate the associations between clinical factors and the overall survival. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee5e8e8c2edcda8b8421656bbe8244a
https://doi.org/10.21203/rs.3.rs-747775/v1
https://doi.org/10.21203/rs.3.rs-747775/v1
Autor:
Chihiro Taka, Takahiro Hirai, Kotaro Tokui, Ryuji Hayashi, Seisuke Okazawa, Kazuyuki Tobe, Minehiko Inomata, Toru Yamada, Toshiro Miwa, Tomomi Ichikawa, Zenta Seto, Shingo Imanishi, Kenta Kambara
Publikováno v:
Pathology & Oncology Research. 26:327-333
We explored the associations between progression-free survival (PFS) after the initiation of PD-1 inhibitor therapy and the clinical parameters in patients with NSCLC. We reviewed the clinical data of patients with NSCLC treated with PD-1 inhibitor.